The group was also more likely to undergo treatment with CCBs (32.6% vs 11.5%), of both dihydropyridine and nondihydropyridine varieties. More than half of the patients who developed POAG utilized ...

Overall, the data showed a reduced dementia risk with non-dihydropyridine calcium channel blockers (HR 0.56, 95% CI: 0.31-1.00; P =0.05) and loop diuretics (HR 0.45, 95% CI: 0.22-0.93; P =0.03 ...

Appearing in the June 6, 2001 issue of JAMA, the paper compares the progression of hypertensive renal disease in patients randomized to either an ACE inhibitor (ramipril) or a dihydropyridine CCB ...